Literature DB >> 29446144

Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis.

Ivana Bjelobaba1, Vesna Begovic-Kupresanin2, Sanja Pekovic1, Irena Lavrnja1.   

Abstract

Multiple sclerosis (MS) is a chronic, progressive disorder of the central nervous system (CNS) that affects more than two million people worldwide. Several animal models resemble MS pathology; the most employed are experimental autoimmune encephalomyelitis (EAE) and toxin- and/or virus-induced demyelination. In this review we will summarize our knowledge on the utility of different animal models in MS research. Although animal models cannot replicate the complexity and heterogeneity of the MS pathology, they have proved to be useful for the development of several drugs approved for treatment of MS patients. This review focuses on EAE because it represents both clinical and pathological features of MS. During the past decades, EAE has been effective in illuminating various pathological processes that occur during MS, including inflammation, CNS penetration, demyelination, axonopathy, and neuron loss mediated by immune cells.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  EAE; ethidium bromide; glial cells; lysolecithin toxin and virus-induced demyelination; multiple sclerosis

Mesh:

Year:  2018        PMID: 29446144     DOI: 10.1002/jnr.24224

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  34 in total

1.  Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.

Authors:  Zinah Zamil Al-Ghezi; Philip Brandon Busbee; Hasan Alghetaa; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Brain Behav Immun       Date:  2019-07-26       Impact factor: 7.217

2.  Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors.

Authors:  Brian E Jones; Kenneth R Tovar; April Goehring; Farzad Jalali-Yazdi; Nana J Okada; Eric Gouaux; Gary L Westbrook
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

3.  Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.

Authors:  J Singh; M Cerghet; L M Poisson; I Datta; K Labuzek; H Suhail; R Rattan; Shailendra Giri
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-12       Impact factor: 4.147

Review 4.  The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Roberta Brambilla
Journal:  Acta Neuropathol       Date:  2019-03-07       Impact factor: 17.088

Review 5.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

6.  Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain.

Authors:  Nitish Kumar; Nidhi Sharma; Rishabh Khera; Ria Gupta; Sidharth Mehan
Journal:  Metab Brain Dis       Date:  2021-02-26       Impact factor: 3.584

7.  ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model.

Authors:  Rheal A Towner; Nataliya Smith; Michelle Zalles; Sara Morris; MacKenzie Toliver; Debra Saunders; Megan Lerner; Gaurav Kumar; Robert C Axtell
Journal:  Mult Scler Relat Disord       Date:  2021-01-22       Impact factor: 4.339

8.  Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Christodoulos Xinaris; Nefeli Zerva; Konstantinos Filippakis; Angelos Pavlopoulos; Constantinos Pantos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

9.  BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models.

Authors:  Guo-Yi Liu; Yan Wu; Fan-Yi Kong; Shu Ma; Li-Yan Fu; Jia Geng
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

10.  Sex differences in EAE reveal common and distinct cellular and molecular components.

Authors:  Jack Wiedrick; Roberto Meza-Romero; Grant Gerstner; Hilary Seifert; Priya Chaudhary; Ashley Headrick; Gail Kent; Ashley Maestas; Halina Offner; Arthur A Vandenbark
Journal:  Cell Immunol       Date:  2020-10-22       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.